Vohr, Hans-Werner
January 2005
Encyclopedic Reference of Immunotoxicology;2005, p83
Reference Entry
The article presents an encyclopedia entry for AZT. AZT or zidovudine is an antiviral drug used in treatment of acquired immunodefiency syndrome.


Related Articles

  • New Report on AZT. Helquist, Michael // Advocate;1/17/89, Issue 516, p30 

    Reports on a study indicating that azidothymidine (AZT) can reverse the deterioration in mental and cognitive capabilities often experienced by individuals with AIDS or AIDS-related complex. Support for anecdotal reports on the benefits of the antiviral drug; Details of the study.

  • OKLAHOMA.  // Advocate;11/3/92, Issue 615, p26 

    Reports that Oklahoma state-subsidized distribution of the antiviral drug, AZT to indigent people will be stopped because of a bureaucratic problem that caused officials at state agencies to fail to report that the program was in jeopardy.

  • AZT combination trial shows positive results.  // Nature;9/28/1995, Vol. 377 Issue 6547, p276 

    Reports on the result of a study on the effects of AZT when given jointly with one of two antiretoviral drugs in patients with HIV or AIDS in London, England.

  • Antiviral Briefs.  // AIDS Patient Care & STDs;Nov2002, Vol. 16 Issue 11, p567 

    Presents news and developments relevant to antiviral drugs compiled as of November 2002. Treatment interruption of antiretroviral therapy; Cases of bradyarrhythmia; Resistance of HIV strains to AZT.

  • YET MORE BUSHWHACKING.  // Advocate;10/9/90, Issue 561, p10 

    Reports on the growing concern over the lack of access to the drug, AZT for HIV-infected people and AIDS patients. Examples of the most common excuses the hinder access to the drug.

  • Another Look at AZT Report. Helquist, Michael // Advocate;1/5/88, Issue 489, p23 

    Reports that AZT may not block indefinitely the progression of AIDS according to study findings from the University of Miami School of Medicine. Details of the study.

  • NEWSFRONT: NORTH CAROLINA.  // Advocate;1/5/88, Issue 489, p31 

    Reports that officials of North Carolina-based Burroughs Wellcome Co. agreed to meet with New York State lawmaker, Gerrold Nadler about their pricing policy for the anti-AIDS drug, AZT.

  • Therapeutic Options Expand, Take New Directions. Goldsmith, Marsha F. // JAMA: Journal of the American Medical Association;8/14/91, Vol. 266 Issue 6, p761 

    Focuses on several therapeutic options against HIV infection as discussed during a satellite meeting held in conjunction with the Seventh International Conference on AIDS in Florence, Italy in 1991. Introduction of data that support early intervention with the administration of antiretroviral...

  • Timing of AZT. M.O.R. // Cortlandt Forum;03/25/97, Vol. 10 Issue 3, p139 

    Warns against the use of zidovudine monotherapy in newly diagnosed HIV patients. Drugs which could be combined with zidovudine to increase anti-HIV activity; Factors on which decisions about when to initiate treatment are usually based.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics